Premium
Letter: treatment for small intestinal bacterial overgrowth – where are we now? Authors' reply
Author(s) -
Sewell J. L.,
Shah S. C.
Publication year - 2014
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12591
Subject(s) - small intestinal bacterial overgrowth , rifaximin , medicine , lactulose , regimen , intensive care medicine , antibiotics , antibiotic therapy , clinical trial , gastroenterology , irritable bowel syndrome , microbiology and biotechnology , biology